Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine
about
Amphetamine and pseudoephedrine cross-tolerance measured by c-Fos protein expression in brains of chronically treated ratsAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsA threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genesNeurotensin-deficient mice show altered responses to antipsychotic drugsHow do the atypical antipsychotics work?Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivityParametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations.30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesMice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects.FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration.Does the difference between physically active and couch potato lie in the dopamine system?c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.Methamphetamine-induced expression of zif268 mRNA is prevented by haloperidol in mice lacking mu-opioid receptor.Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptorsMonoaminergic synapses and schizophrenia: 45 years of neuroleptics.Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineDopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.Intracellular modulation of NMDA receptor function by antipsychotic drugsAntipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.Identification of optogenetically activated striatal medium spiny neurons by Npas4 expressionIncreased conditioned place preference for cocaine in high anxiety related behavior (HAB) mice is associated with an increased activation in the accumbens corridorFunctional genomics in neuropsychiatric disorders and in neuropharmacology.Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.Pharmacogenomics in the treatment of narcolepsy.Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptorRole of monoamine systems in activation of zif268 by cocaineExposure to extremely low frequency magnetic fields induces fos-related antigen-immunoreactivity via activation of dopaminergic d1 receptor.Relevance of animal models to human tardive dyskinesia.The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum.c-Fos immunoreactivity in prefrontal, basal ganglia and limbic areas of the rat brain after central and peripheral administration of ethanol and its metabolite acetaldehyde.2-Bromoterguride-a potential atypical antipsychotic drug without metabolic effects in rats.DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains.Gene expression profiling as functional readout of rodent models for psychiatric disorders.L-type voltage-sensitive Ca2+ channel activation regulates c-fos transcription at multiple levels.MR contrast probes that trace gene transcripts for cerebral ischemia in live animals.Involvement of a single-stranded DNA binding protein, ssCRE-BP/Pur alpha, in morphine dependence.Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.Dynamic interaction between medial prefrontal cortex and nucleus accumbens as a function of both motivational state and reinforcer magnitude: a c-Fos immunocytochemistry study.
P2860
Q21262022-0D00725E-3FB9-41D3-BCEB-99009FB1B1F0Q22251215-95AE4811-BDCD-494D-A59A-1F16483E0018Q23914101-A286548E-E721-45B6-90F1-C37CA7DC26D6Q24632801-AC9897BA-FC46-4924-A4A0-B898A997776BQ28344179-4918AE28-744D-4CDA-B5D5-3E4D78943767Q28369508-39129E01-FA9A-4936-B0EA-3CC3A1527A60Q30390855-499743E4-6D54-4D82-8C43-40E90A486563Q30428213-7167FDCB-34F5-4B34-8A9D-89A0006E1FF4Q30455338-58A588AA-FB58-47D7-B791-3F462A18E597Q30481450-AD2CBCFD-72A5-4666-983E-6D7E751BD7F9Q30670738-AF8945EF-7AC7-49E0-A4E5-581CBD46F3DDQ31949056-525CB510-A2DF-419A-AA44-3D1C7F2D7A29Q33719306-A5966AC5-5422-4AE9-B4FA-8ADBBC5E4AEAQ33725056-0DD9FEA9-48FF-42CA-800F-489AA141ABCBQ33838164-6C612A37-3CE7-47CA-AEF4-7BE7EF0E3C75Q33915563-5697FB0C-D001-4D01-BBF4-9FA55659034FQ34013426-97EA7E9A-7693-488B-91F0-E0F1E1693304Q34129991-76CE0AB8-27D1-4118-803F-B761C95C194DQ34372135-57B9221A-B07D-4292-8A6E-C57BFEB80696Q34372226-292F039D-C3A2-42EC-8E36-9A37EA5AAE50Q34383654-4EB22468-9A16-430E-93BA-E35096199BF1Q34541204-35CE926B-8D21-468E-BA93-7721FA6B5564Q34755577-E40EBF73-74D2-41E2-BF55-9172072D5BC9Q34837434-FFFC7F22-1343-4AF7-8EF1-90E03AF25F9AQ34980328-A519D9DB-473A-4BA0-9D3E-73B56DFD73BFQ35040879-8900ADCC-2893-4E01-BF8D-7969555E0838Q35188101-82229886-588D-4602-B350-6A4E4CF33999Q35266322-7F1AFFFD-A697-4C53-B945-F82561DAC9C1Q35545917-A2255A79-CB04-41A7-BE51-69BB2A81C573Q35916870-45018E34-0492-4082-9869-D870FE817867Q36445408-9758D001-D9C1-4826-91BB-F1842D3E75E8Q36871808-4E9989E3-797B-4589-B3E3-307FC9A1BB8DQ37067125-D244AFEC-7DB1-417D-96EC-0A1567885775Q37352241-04F96DBF-84E7-475D-937B-03AF28A6325FQ38109500-362B709D-46F9-4AEA-8A71-3C1A21F17704Q38297922-4ED65178-8501-4F3E-84A4-EC70B30EC88AQ38302094-E148F96A-3305-4F85-ABF4-C875FC06B0A7Q38354325-B8A2489B-2C01-48E8-BB3F-D61B575E5056Q38355902-DC57ED32-BBE8-46E4-80A1-4913862848AFQ39240562-CA728F3E-B3D2-4B60-A7E7-B9C87BF0C912
P2860
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential expression of c-f ...... ol, clozapine, and amphetamine
@en
Differential expression of c-f ...... l, clozapine, and amphetamine.
@nl
type
label
Differential expression of c-f ...... ol, clozapine, and amphetamine
@en
Differential expression of c-f ...... l, clozapine, and amphetamine.
@nl
prefLabel
Differential expression of c-f ...... ol, clozapine, and amphetamine
@en
Differential expression of c-f ...... l, clozapine, and amphetamine.
@nl
P2093
P2860
P356
P1476
Differential expression of c-f ...... ol, clozapine, and amphetamine
@en
P2093
B E Kosofsky
R Birnbaum
T V Nguyen
P2860
P304
P356
10.1073/PNAS.89.10.4270
P407
P577
1992-05-01T00:00:00Z